Details for 2012807786
Up to date per 04.04.2026
Actions
Details for 2012807786
Granted/Registered
European Patent
07.05.2014 A
07.08.2019 B1
01.07.2011
US
201161504128 P
04.08.2011
US
201161515126 P
C07K 19/00 20060101AFI20151029BHEP
Owner
NGM Biopharmaceuticals, Inc.333 Oyster Point Blvd. South San Francisco CA 94080US
Representative
Representative
Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT
Inventor
LING, Lei411 Nantucket Street Foster City, CA 94404US
LINDHOUT, Darrin, A.1533 Miramonte Avenue Mountain View, CA 94040US
Information about Fees